LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,317,837 | -45.0% | 2,126,137 | +15.5% | 0.00% | – |
| Q2 2023 | $4,214,600 | +0.5% | 1,840,437 | +6.7% | 0.00% | -100.0% |
| Q1 2023 | $4,192,743 | +136427.0% | 1,725,409 | +7.3% | 0.00% | – |
| Q4 2022 | $3,071 | -99.9% | 1,607,941 | +2.5% | 0.00% | -100.0% |
| Q3 2022 | $3,765,000 | +50.9% | 1,569,022 | +17.0% | 0.00% | – |
| Q2 2022 | $2,495,000 | -5.1% | 1,341,413 | +6.6% | 0.00% | – |
| Q1 2022 | $2,628,000 | -44.3% | 1,257,864 | +5.0% | 0.00% | -100.0% |
| Q4 2021 | $4,719,000 | -17.8% | 1,197,739 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $5,742,000 | -2.3% | 1,193,922 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $5,878,000 | -7.1% | 1,280,654 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $6,328,000 | +140.5% | 1,078,158 | +40.1% | 0.00% | – |
| Q4 2020 | $2,631,000 | +136.0% | 769,588 | -0.7% | 0.00% | – |
| Q3 2020 | $1,115,000 | -31.7% | 774,957 | -5.4% | 0.00% | – |
| Q2 2020 | $1,633,000 | +22.0% | 818,875 | +19.3% | 0.00% | – |
| Q1 2020 | $1,338,000 | -75.9% | 686,302 | -48.8% | 0.00% | -100.0% |
| Q4 2019 | $5,562,000 | +175.2% | 1,340,274 | +99.6% | 0.00% | – |
| Q3 2019 | $2,021,000 | -50.8% | 671,570 | +2.8% | 0.00% | -100.0% |
| Q2 2019 | $4,107,000 | +18.6% | 652,982 | +4.8% | 0.00% | 0.0% |
| Q1 2019 | $3,464,000 | -53.8% | 623,120 | -44.9% | 0.00% | 0.0% |
| Q4 2018 | $7,504,000 | +27.6% | 1,130,170 | +105.0% | 0.00% | -50.0% |
| Q3 2018 | $5,883,000 | -7.2% | 551,421 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $6,338,000 | +63.7% | 528,170 | +16.9% | 0.00% | +100.0% |
| Q1 2018 | $3,871,000 | -11.7% | 451,742 | +1.8% | 0.00% | 0.0% |
| Q4 2017 | $4,384,000 | -17.5% | 443,819 | +2.6% | 0.00% | -50.0% |
| Q3 2017 | $5,317,000 | -23.6% | 432,650 | +2.3% | 0.00% | -33.3% |
| Q2 2017 | $6,955,000 | +11.9% | 422,822 | -2.4% | 0.00% | 0.0% |
| Q1 2017 | $6,215,000 | +4.7% | 433,420 | +1.0% | 0.00% | 0.0% |
| Q4 2016 | $5,936,000 | -19.6% | 429,279 | +5.0% | 0.00% | -25.0% |
| Q3 2016 | $7,386,000 | +23.6% | 408,797 | -1.8% | 0.00% | +33.3% |
| Q2 2016 | $5,974,000 | +41.6% | 416,357 | +17.9% | 0.00% | +50.0% |
| Q1 2016 | $4,220,000 | -0.8% | 353,192 | +10.5% | 0.00% | 0.0% |
| Q4 2015 | $4,253,000 | +30.8% | 319,594 | +5.6% | 0.00% | 0.0% |
| Q3 2015 | $3,251,000 | +34.6% | 302,765 | +0.9% | 0.00% | +100.0% |
| Q2 2015 | $2,416,000 | – | 300,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |